Tracing-corrected estimates of disengagement from HIV care and mortality among patients enrolling in HIV care without overt immunosuppression in Tanzania.
Adult
Anti-HIV Agents
/ therapeutic use
Antiretroviral Therapy, Highly Active
Child
Continuity of Patient Care
Female
HIV Infections
/ drug therapy
Humans
Immunosuppression Therapy
Kaplan-Meier Estimate
Lost to Follow-Up
Male
Quality of Life
/ psychology
Retention in Care
Social Environment
Social Stigma
Social Support
Tanzania
/ epidemiology
HIV/AIDS
Retention
sub-Saharan Africa
tracing study
Journal
AIDS care
ISSN: 1360-0451
Titre abrégé: AIDS Care
Pays: England
ID NLM: 8915313
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
pubmed:
13
12
2019
medline:
11
2
2021
entrez:
13
12
2019
Statut:
ppublish
Résumé
In the era of "test and treat", it is important to understand HIV care outcomes and their determinants in patients presenting to care with early-stage disease. We surveyed 924 adults newly enrolling in HIV care at four clinics in Tanzania before the adoption of universal treatment eligibility, and collected longitudinal clinical data. Participants who defaulted from care were tracked in the community. Cumulative incidence of disengagement from care and death was estimated using competing risk methods. By 12 months after enrollment, 18.2% of patients had disengaged from care and 6.9% had died. Factors associated with disengagement included male sex (adjusted subhazard ratio [aSHR] versus female = 1.75, 95% confidence interval [CI]: 1.06-2.89), provider-initiated HIV diagnosis (aSHR versus self-referred = 1.71, 95% CI: 1.03-2.86), ineligibility for antiretroviral treatment (ART) at enrollment (aSHR versus eligibility = 2.82, 95% CI: 1.84-4.32) and increased anticipated stigma score (aSHR = 1.04 per 5-point increase, 95% CI: 1.02-1.05). Higher life satisfaction score (aSHR = 0.97 per 5-point increase, 95% CI: 0.95-0.99) and having 1-2 close friends (aSHR versus none = 0.58, 95% CI: 0.47-0.71) were protective. The findings highlight the continued importance of social environment for HIV care outcomes and the potential of universal ART eligibility to reduce HIV care attrition.
Identifiants
pubmed: 31826640
doi: 10.1080/09540121.2019.1699642
pmc: PMC7286784
mid: NIHMS1546443
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
47-53Subventions
Organisme : NICHD NIH HHS
ID : P2C HD050924
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH089831
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH019139
Pays : United States
Références
Indian J Community Med. 2016 Jul-Sep;41(3):241-4
pubmed: 27385880
BMJ Open. 2018 Apr 20;8(4):e017487
pubmed: 29678963
AIDS. 2014 Mar;28 Suppl 2:S187-204
pubmed: 24849479
Clin Infect Dis. 2017 May 15;64(10):1309-1316
pubmed: 28329244
PLoS Med. 2011 Jul;8(7):e1001056
pubmed: 21811403
PLoS Med. 2017 Nov 28;14(11):e1002463
pubmed: 29182641
BMJ Open. 2015 Jun 24;5(6):e006927
pubmed: 26109110
AIDS Behav. 2018 Mar;22(3):752-764
pubmed: 27990582
Clin Infect Dis. 2013 Nov;57(9):1343-50
pubmed: 23899683
AIDS. 2014 Mar;28 Suppl 2:S175-85
pubmed: 24849478
J Acquir Immune Defic Syndr. 2015 May 1;69(1):98-108
pubmed: 25942461
Trop Med Int Health. 2017 Aug;22(8):1021-1029
pubmed: 28544728
AIDS. 2017 Apr 24;31(7):953-963
pubmed: 28121710
Qual Life Res. 1997 Aug;6(6):561-71
pubmed: 9330555
AIDS Care. 2007 Sep;19(8):1002-12
pubmed: 17851997
Trop Med Int Health. 2017 Apr;22(4):375-387
pubmed: 28102610
Med Care. 1998 Feb;36(2):138-54
pubmed: 9475469
Lancet Infect Dis. 2011 Dec;11(12):942-51
pubmed: 22030332
AIDS. 2014 Feb 20;28(4):559-68
pubmed: 24076661
Clin Infect Dis. 2018 Mar 5;66(6):893-903
pubmed: 29373672